Best Forex (Click Here For Best Forex Techniques) robot
ZURICH/BERLIN, July 7 (Reuters) – The Swiss blue-chip SMI was seen opening 0.3%lower at 10,226 points on Tuesday, according to premarket indications from bank Julius Baer.
Here are some of the primary factors that may impact Swiss stocks:
The World Health Company (WHO) is reviewing a report that suggested its advice on the unique coronavirus needs updating, after some scientists told the New York Times there was evidence the infection could be spread out by small particles in the air.
More than a third of the world’s nations state they are at risk of lacking life-saving AIDS drugs due to the fact that of disturbances to provide lines and other issues caused by the COVID-19 pandemic, the WHO said on Monday.
GAM Investments’ head of sales and circulation, Tim Rainsford, is leaving the possession management group amidst a management revamp, GAM stated on Monday.
* Molecular Partners: The biotech group said it had actually completed a share positioning of 5.5 million shares at 14.50 Swiss francs per share via an accelerated bookbuilding process. The shares are to be provided from existing authorised share capital under an exemption of existing investors’ pre-emptive rights. It said it would use the earnings to fund research study and advancement costs and for general business purposes.
* Novartis AG: receives EC approval for Enerzair Breezhaler, consisting of very first digital companion (sensing unit and app) that can be recommended alongside a treatment for uncontrolled asthma in EU
* Von Roll Holding AG: strengthens its presence in India and receives a major order from the wind market
* OC Oerlikon Corporation AG Pfaeffikon: First Oerlikon nonwoven meltblown innovation plant offered to Australia; Australian production of medical masks to commence from April 2021 with Oerlikon nonwoven meltblown innovation
SCHINDLER HOLDING AG: BERENBERG RAISES TO PURCHASE FROM HOLD, RAISES TARGET COST TO CHF 275 FROM CHF 215
GEBERIT AG: MORGAN STANLEY RAISES TARGET RATE TO CHF 454 FROM CHF 446
OBSEVA SA: JP MORGAN CUTS TO NEUTRAL FROM OVERWEIGHT, CUTS TARGET PRICE TO $5 FROM $18
UBS GROUP AG: CREDIT SUISSE RAISES TARGET RATE TO CHF 14.00 FROM CHF 13.50
SWISS RE AG: JP MORGAN CUTS TARGET RATE TO CHF 96 FROM CHF 98
JULIUS BAER GRUPPE AG: JPMORGAN RAISES RATE TARGET TO CHF 48 FROM CHF 45
Swiss June Forex (Click Here For Best Forex Techniques) reserves due at about 0700 GMT. (Reporting by Zurich newsroom and Berlin Speed Desk)